Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: July 2012

Chapter 67 - Antiepileptic drug pharmacokinetics and therapeutic drug monitoring

from Section 5 - Management of epilepsy

Related content

Powered by UNSILO

Recommended reading

Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: A position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239–76.
Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004;43:707–24.
Williams J, Bialer M, Johannessen SI, et al. Interlaboratory variability in the quantification of new generation antiepileptic drugs based upon external quality assessment data. Epilepsia 2003;44:40–5.
Johannessen SI, Bettino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 2003;25:347–63.
Patsalos PN, Ghattaura S, Ratnaraj N, Sander JW. In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 2006;47:1818–21.